US Patent 10927120 CDK inhibitors
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+127 characters)
Article
Patent abstract
Compounds of Formulae I, II or III, and pharmaceutically acceptable salts thereof, are useful as CDK inhibitors.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 10 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
109271200
Date of Patent
February 23, 2021
0Patent Application Number
159313300
Date Filed
May 13, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Patent Jurisdiction
Patent Number
109271200
Date of Patent
February 23, 2021
0Patent Application Number
159313300
Date Filed
May 13, 2020
0Official Website
Patent Citations
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 10 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10927120 CDK inhibitors
Infobox
Is a
Patent applicant
Patent jurisdiction
Patent number
10927120
Date of patent
February 23, 2021
Patent application number
15931330
Date Filed
May 13, 2020
Patent citations
Patent primary examiner
Find more entities like US Patent 10927120 CDK inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.